Skip to main content
. 2017 May 17;9(2):102–107. doi: 10.15171/jcvtr.2017.17

Table 3. Changes in laboratory test results of patients after three months of treatment with allopurinol .

Index At baseline After treatment P value
BUN, mg/dL, mean (SD) 21.2 (6.6) 22.6 (12.0) 0.33
Cr, mg/dL, mean (SD) 0.9 (0.2) 0.9 (0.2) 0.84
Hb, g/dl, mean (SD) 13.3 (1.9) 13.2 (1.8) 0.82
Mg, mg/dL, mean (SD) 1.9 (0.1) 2.1 (0.1) 0.07
K, mg/dL, mean (SD) 4.2 (0.4) 4.1 (0.5) 0.29
Uric acid, mg/dL, mean (SD) 5.9 (1.3) 3.1 (0.9) <0.001
AST, units/L, mean (SD) 20.9 (6.3) 20.8 (6.7) 0.81
ALT, units/L, median (IQR) 21 (17-24) 20 (17-24) 0.51
ALP, units/L, mean (SD) 219.2 (68.2) 226.1 (68.8) 0.70
Total bilirubin, mg/dL, median (IQR) 0.9 (0.5-1.1) 0.9 (0.5-1.1) 0.59
Direct bilirubin, mg/dL, mean (SD) 0.3 (0.1) 0.2 (0.1) 0.14
ESR, mm/h, mean (SD) 24 (17.6) 16 (12.3) <0.001
hs-CRP, mg/L, median (IQR) 4.8 (4.7-5.2) 5 (4.1-5.4) 0.71
NT-pro BNP, ng/mL, median (IQR) 782 (522.7-1000) 630 (405-895.7) <0.001

Abbreviations; BUN, blood urea nitrogen; Cr, creatinine; Hb, hemoglobin; Mg, magnesium; K, potassium; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; ESR: erythrocyte sedimentation rate; hs-CRP: high sensitivity C reactive protein; NT-pro BNP, N terminal pro brain type natriuretic peptide; SD, standard deviation; IQR, interquartile range.